I couldn't agree more with Dr. Christoph Bug, MD, PhD, MBA's take on why:
1) Knowing the impact of your medical affairs organization is critical
2) This has been the holy grail forever for medical affairs teams
3) It will be growing in its criticality for medical affairs teams to have tangible metrics in place to show this and use this to guide activities
H1 for the past 2yrs have been working on getting in place metrics for top 20 pharma companies around knowing the impact of your medical affairs organization. The level of insight this has given to these organizations has transformed the way they have been approaching:
1) Engaging with HCPs
2) Content and Medcoms
3) Investment decisions
Thank you Dr. Christoph Bug, MD, PhD, MBA for further highlighting the market need for this.
For those interested, we're happy to share live blinded examples of how this looks in practice for top 20 pharma companies.
Measuring medical impact is tough without an industry-wide standard.
Check out insights and 4 takeaways from my recent chat with experts on the need for compliant impact metrics.
Based on this feedback, we’ve partnered with industry leaders to develop a practical model for measuring medical impact.
See us at the #MAPS2024 Americas conference (booth 708) to get an exclusive first look or subscribe to receive the info in your inbox after the conference - https://bit.ly/4a2n216
#medicalaffairs #pharmaceuticals #medicalscienceliaison